Replies to post #4369 on Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

FOTD, wasn't the HA status of the patients cleared up with the subsequent adoption of the Ventana method?
-Fritz

[rod5247]

Well, while I am on a roll.

I tend to simplify when I can.

Does rhuph20 remove HA? I feel secure in saying it does.

Does HA restrict drug access to tumors? I feel secure saying it does.

Does drug access to tumor yield better results. My logic and common sense is screaming, it has to. The clinical trials will prove it or not.

I do not believe whether rhuph20 depletes HA or not is in question.

At this stage I am not so much concerned with the spending as I am the cash burn. Have a lot of speculative thoughts that I will keep to myself.

If you look at 2015 with $175 million projected spending with $30-$40 million cash burn and the actual burn will be close to zero, the possibility of a relatively low cash burn for 2016 exist.